-
Whole transcriptome sequencing of pediatric T-cell acute lymphoblastic leukemia
Study
JGAS000090
-
Whole-exome sequencing of pediatric solid tumors
Study
JGAS000036
-
Comprehensive analyses of genetic aberrations in cholangiolocarcinoma
Study
JGAS000597
-
Bisulfite sequencing of cell-free DNA in NMOSD patients
Study
JGAS000515
-
Genomic Profiling Reveals Heterogeneous Populations of Ductal Carcinoma In Situ
Study
JGAS000202
-
Altered Blood and Keratinocyte microRNA/transfer RNA Fragment Profiles Related to Fibromyalgia Syndrome and its Severity
Study
EGAS50000000638
-
Multimodal epigenetic sequencing analysis of cell-free DNA identifies biomarkers for ALS diagnosis and progression
Dac
EGAC50000000739
-
DAC for study "Single-nucleus brain transcriptomics reveals microglia dysfunction in Multiple System Atrophy"
Dac
EGAC50000000809
-
Transcriptional and epigenetic profiling of bone marrow blood progenitors across age
Study
EGAS50000001623
-
InsPIRE islets
Study
EGAS00001003997
-
Celiac disease case-control North Indian Immunochip dataset
Study
EGAS00001000849
-
Breast Cancer PDTX Encyclopaedia
Study
EGAS00001001913
-
Shwachman_Diamond_syndrome__SDS___Exome_sequencing
Study
EGAS00001000264
-
HCA_Thymus_Paediatric_ThyDesign_RNA_Managed_Access
Study
EGAS00001007687
-
Genetics_of_gene_expression_in_human_macrophage_response_to_Salmonella
Study
EGAS00001002236
-
Edinburgh_Naevi_Cohort
Study
EGAS00001002347
-
Deciphering RBP - alternative splicing networks in ALS iPSC-MN: TDP-43, NOVA1, NOVA2 and RBFOX2 eCLIP-seq
Study
EGAS00001005880
-
BLUEPRINT ATAC-seq data for cells in the haematopoietic lineages, from adult and cord blood samples
Study
EGAS00001001596
-
Whole exome and whole genome sequencing of juvenile myelomonocytic leukemia (JMML)
Study
EGAS00001000521
-
ChIP-seq data of Hodgkin lymphoma cell line L-428
Study
EGAS00001003033
-
Metastatic_Breast_Cancer_Whole_Genome
Study
EGAS00001000902
-
BASIS_RNAseq
Study
EGAS00001000707
-
The Druze analysis group
Study
EGAS00001000963
-
Whole genome DNA sequencing for two long-lived humans.
Study
EGAS00001000877
-
Balanced_Ependymoma
Study
EGAS00001000174
-
Breast_Cancer_FRT_RNA_seq
Study
EGAS00001000420
-
Monotherapy_Breast_Cancer
Study
EGAS00001000165
-
Lung_Multi_site_Targeted_Sequence_Capture
Study
EGAS00001000436
-
(h)MeDIP-Seq of high-risk prostate cancer
Study
EGAS00001001019
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000551
-
Microbial signatures and innate immune gene expression in lamina propria phagocytes of inflammatory bowel diseases patients
Study
EGAS00001003105
-
Breast_Cancer_Whole_Genome_Sequencing
Study
EGAS00001000210
-
Triple_Negative_Breast_Cancer_RNA_Sequencing
Study
EGAS00001000377
-
Moles
Study
EGAS00001000789
-
Multisite_Primary_Breast_Cancer
Study
EGAS00001000891
-
GWAS and Meta-analysis on Frontal Fibrosing Alopecia in two European Populations
Study
EGAS00001003460
-
BLUEPRINT Epigenetic characterization of megakaryocytes and erythroblasts
Study
EGAS00001001641
-
BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia
Study
EGAS00001004810
-
arrayCGH for copy number profiling on tumor DNA from pediatric cancer tissue samples
Study
EGAS00001005197
-
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL
Study
EGAS00001005181
-
eccDNA in maternal plasma
Study
EGAS00001003827
-
COIN CRC GWAS data
Study
EGAS00001005421
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
NLG-LBC-05 ctDNA
Study
EGAS00001005835
-
INDIA
Study
EGAS00001006417
-
RNAseq of liver harvested from CDAHFD mice treated for 8 weeks with either the MGAT2 inhibitor compound BMS-963272 or vehicle
Study
EGAS00001006583
-
Comprehensive de novo variant discovery with HiFi long-read sequencing
Study
EGAS00001006479
-
10X 3' V2 data of single immune cells in hepatocellular carcinoma
Dataset
EGAD00001005961
-
Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient
Dataset
EGAD00001005901